What Researchers Did
Researchers retrospectively analyzed the outcomes and difficulties of hyperbaric oxygen treatment (HBOT) in 54 infants aged 12 months or younger across two different institutions.
What They Found
The median age of the 54 infants was 3.5 months, with acute carbon monoxide intoxication being the major HBOT indication for 32 patients. Acute signs fully resolved in 40 patients (74%), and no complications related to HBOT were reported.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen treatment (HBOT) may be a safe and effective option for Canadian infants with specific indications. Paediatricians in Canada could consider HBOT for infants, including preterm babies, when clinically appropriate.
Canadian Relevance
This study was conducted in two tertiary care centres outside of Canada, therefore its direct relevance to the Canadian healthcare system is limited.
Study Limitations
This retrospective study's limitations include its small sample size of 54 infants and its design, which may not fully capture all potential risks or long-term outcomes.